China Health Industries Holdings Inc. Stock Analysis CHHE
United States Consumer Staples Nano Cap China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm's products include soft capsule, hard capsule, tablet, granule, oral liquid forms which address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.
Read More China Health Industries Holdings Inc (CHHE) Chart
Key Statistics of China Health Industries Holdings Inc (CHHE)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
176.00P/E Ratio (TTM)
-52 Week Range
Market Cap
10.00KAvg. Volume
176.00Dividend Yield
-Financial Metrics & Statements of China Health Industries Holdings Inc (CHHE)
FAQ's for China Health Industries Holdings Inc (CHHE)
- According to Musaffa’s Shariah screening methodology, China Health Industries Holdings Inc (CHHE) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.